<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Plasma norepinephrine and survival in HF</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Plasma norepinephrine and survival in HF</h1>
<div class="graphic"><div class="figure"><div class="ttl">Plasma norepinephrine and survival in HF</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Percent probability of survival in patients with advanced heart failure according to the plasma norepinephrine concentration. Survival was inversely related to the degree of norepinephrine activation, a presumed reflection of worsening cardiac function. The time to 50 percent survival was approximately 30 months in patients with normal norepinephrine levels (200 pg/mL) but only about 10 months in those with marked hypersecretion (1200 pg/mL).</div><div class="graphic_reference">Data from: Cohn JN, Levine TB, Olivaro MT, et al. N Engl J Med 1984; 311:819.</div><div id="graphicVersion">Graphic 62001 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
